Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone alone versus methylprednisolone + mycophenolate mofetil for IgA nephropathy
ChiCTR-TRC-09000607Phase 4Completed
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Sep 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylprednisolone and mycophenolate mofetil in IgA nephropathy (IgAN) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoints: Renal function and 24-hour urine protein. Started Sep 2014; status: completed.
02
Drugs
methylprednisolonemycophenolate mofetil
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on ChiCTR-TRC-09000607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000607.